EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Benchmarking pharmacogenomics genotyping tools: Performance analysis on short‐read sequencing samples and depth‐dependent evaluation

Andreas Halman iD, Sebastian Lunke iD, Simon Sadedin iD, Claire Moore iD, Rachel Conyers iD

Clinical and Translational Science · 2024

DOI: 10.1111/cts.13911 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, 2024. Verfasst von Andreas Halman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Therapies, Stem Cell Medicine, Murdoch Children's Research Institute, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Benchmarking, Cytochrome P-450 CYP2D6, Pharmacogenetics. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharmacogenomics (PGx) investigates the influence of genetics on drug responses, enabling tailored treatments for personalized healthcare. This study assessed the accuracy of genotyping six genes using whole genome sequencing with four different computational tools and various sequencing depths. The effects of using different reference genomes (GRCh38 and GRCh37) and sequence aligners (BWA‐MEM and Bowtie2) were also explored. The results showed generally minor variations in tool performance across most genes; however, more notable discrepancies were observed in the analysis of the complex CYP2D6 gene. Cyrius, a CYP2D6 ‐specific tool, demonstrated the most robust performance, achieving the highest concordance rates for CYP2D6 in all instances, comparable to the consensus approach in most cases. There were rather small differences between the samples with 20× coverage depth and those with higher depth, but the decreased performance was more evident at lower depths, particularly at 5×. Additionally, variations in CYP2D6 results were observed when samples were aligned to different reference genomes using the same method, or to the same genome using different aligners, which led to reporting incorrect rare star alleles in several cases. These findings inform the selection of optimal PGx tools and methodologies as well as suggest that employing a consensus approach with two or more tools might be preferable for certain genes and tool combinations, especially at lower sequencing depths, to ensure accurate results. Additionally, we show how the upstream alignment can affect the performance of tools, an important factor to take into account.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenchmarkingCytochrome P-450 CYP2D6PharmacogeneticsHumansCytochrome P-450 CYP2C19Whole Genome SequencingGenotyping TechniquesGenotypeCytochrome P-450 CYP2C9Cytochrome P-450 CYP2A6Pharmacogenomic TestingHigh-Throughput Nucleotide SequencingVitamin K Epoxide Reductases

Substanzen

Cytochrome P-450 CYP2D6Cytochrome P-450 CYP2C19CYP2C19 protein, humanCytochrome P-450 CYP2C9CYP2C9 protein, humanCYP2A6 protein, humanCytochrome P-450 CYP2A6VKORC1 protein, humanVitamin K Epoxide Reductases

Autor:innen und Institutionen

  • Cancer Therapies, Stem Cell Medicine, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
  • School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
  • Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia.
  • The Novo Nordisk Foundation Centre for Stem Cell Medicine, ReNEW, Melbourne Node, Parkville, Victoria, Australia.
  • Children's Cancer Centre, The Royal Children's Hospital, Parkville, Victoria, Australia.

ORCID-Profile: Andreas Halman, Sebastian Lunke, Simon Sadedin, Claire Moore, Rachel Conyers

Zitieren

APA

Halman, A., Lunke, S., Sadedin, S., Moore, C., & Conyers, R. (2024). Benchmarking pharmacogenomics genotyping tools: Performance analysis on short‐read sequencing samples and depth‐dependent evaluation. Clinical and Translational Science. https://doi.org/10.1111/cts.13911

Vancouver

Halman A, Lunke S, Sadedin S, Moore C, Conyers R. Benchmarking pharmacogenomics genotyping tools: Performance analysis on short‐read sequencing samples and depth‐dependent evaluation. Clinical and Translational Science. 2024. doi:10.1111/cts.13911

BibTeX
@article{Halman2024,
  author = {Halman, Andreas and Lunke, Sebastian and Sadedin, Simon and Moore, Claire and Conyers, Rachel},
  title = {Benchmarking pharmacogenomics genotyping tools: Performance analysis on short‐read sequencing samples and depth‐dependent evaluation},
  journal = {Clinical and Translational Science},
  year = {2024},
  doi = {10.1111/cts.13911}
}
Kostenlos starten →